| 1 | Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic | 2ᵒ autor: Vela-Ojeda J., Arellano-Llamas A.A., Hernandez-Caballero A. | 2022 | CURRENT ONCOLOGY REPORTS | WoS-id: 000751954700005
Scopus-id: 2-s2.0-85123245478
| 13 | 18 |
| 2 | Abo Blood Group, Atherothrombotic Comorbidities, and COVID-19: A Case-Control Study of their Association in the Mexican Population | Coautor: Vela-Ojeda J., Gamboa-Aguilar J., Zamorano-Montaño Á.C., Enríquez-Osorio A., et al. | 2022 | Archives Of Medical Research | WoS-id: 000753961200013
Scopus-id: 2-s2.0-85116933799
| 4 | 4 |
| 3 | Clinical relevance of NKT cells and soluble MIC-A in Hodgkin lymphoma | 1ᵉʳ autor: Vela-Ojeda J., Perez-Retiguin F.D.C., Olivas-Bejarano A.C., Garcia-Ruiz Esparza M.A., et al. | 2021 | LEUKEMIA & LYMPHOMA | WoS-id: 000596979200001
Scopus-id: 2-s2.0-85097316047
| 9 | 9 |
| 4 | FLT3-ITD and CD135 Over-Expression are Frequent Findings of Poor Survival in Adult Patients with Acute Leukemias | 1ᵉʳ autor: Vela-Ojeda J., Cardenas P.V., Garcia-Ruiz Esparza M.A., Montiel Cervantes L.A., et al. | 2021 | Archives Of Medical Research | WoS-id: 000621872900010
Scopus-id: 2-s2.0-85093925861
| 8 | 9 |
| 5 | Ixazomib-lenalidomide-dexamethasone in routine clinical practice: Effectiveness in relapsed/refractory multiple myeloma | Coautor: Vela-Ojeda J., Hájek R., Minarík J., Straub J., et al. | 2021 | FUTURE ONCOL | WoS-id: 000632872300001
Scopus-id: 2-s2.0-85108000931
| 14 | 17 |
| 6 | Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US | Coautor: Vela-Ojeda J., Davies F., Rifkin R., Costello C., et al. | 2021 | ANNALS OF HEMATOLOGY | WoS-id: 000648835300001
Scopus-id: 2-s2.0-85105553613
| 24 | 27 |
| 7 | Important decrease in invariant natural killer T, CD4+ regulatory T cells, CD8+ regulatory T cells, gamma-delta T cells, and CD4+ T lymphocytes in HIV-negative patients with hemophilia | 1ᵉʳ autor: Vela-Ojeda J., Garcia-Chavez J., Majluf-Cruz A., Reyes-Maldonado E., et al. | 2021 | BLOOD COAGUL FIBRIN | WoS-id: 000661965500002
Scopus-id: 2-s2.0-85100070005
| 0 | 0 |
| 8 | Prescription Patterns of Daratumumab in Patients with Multiple Myeloma in Underprivileged Circumstances: A Multicenter Experience in Mexico | 1ᵉʳ autor: Vela-Ojeda J., Gómez-Almaguer D., Espinoza-Zamora R., Ramírez-Alvarado A.G., et al. | 2021 | Archives Of Medical Research | WoS-id: 000685514200007
Scopus-id: 2-s2.0-85102148656
| 1 | 3 |
| 9 | Análisis de la calidad de la anticoagulación con antagonistas de la vitamina K en tres escenarios clínicos en México | Coautor: Vela-Ojeda J., Gómez-Rosas P., Sosa-Velázquez M.Á., Yáñez-Funes L.A., et al. | 2021 | GACETA MEDICA DE MEXICO | WoS-id: 000721674800012
Scopus-id: 2-s2.0-85119311367
| 1 | 1 |
| 10 | Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato-Oncology (HOLA) Observational Study, 2008?2016 | Coautor: Vela-Ojeda J., de Moraes Hungria V.T., Martínez-Baños D.M., Peñafiel C.R., et al. | 2020 | BRITISH JOURNAL OF HAEMATOLOGY | WoS-id: 000509090800016
Scopus-id: 2-s2.0-85078559893
| 27 | 30 |
| 11 | von Willebrand Disease and other hereditary haemostatic factor deficiencies in women with a history of postpartum haemorrhage | Coautor: Vela Ojeda J., Majluf-Cruz K., Anguiano-Robledo L., Calzada-Mendoza C.C., et al. | 2020 | Haemophilia | WoS-id: 000509833600022
Scopus-id: 2-s2.0-85076344212
| 6 | 7 |
| 12 | Pathophysiology of Alloimmunization | Coautor: Vela-Ojeda J., Molina-Aguilar R., Gómez-Ruiz S., Montiel-Cervantes L.A., et al. | 2020 | TRANSFUS MED HEMOTH | WoS-id: 000526986600007
Scopus-id: 2-s2.0-85070614747
| 7 | 10 |
| 13 | ?d T Cells Number, CD200, and Flt3 Expression Is Associated with Higher Progression Free Survival in Patients with Chronic Myeloid Leukemia | Coautor: Vela-Ojeda J., Molina-Aguilar R., Montiel-Cervantes L.A., Anguiano-Peñaloza S.V., et al. | 2020 | Archives Of Medical Research | WoS-id: 000536139200002
Scopus-id: 2-s2.0-85080147445
| 2 | 2 |
| 14 | Post-treatment improvement of NK cell numbers predicts better survival in myeloma patients treated with thalidomide-based regimens | 1ᵉʳ autor: Vela-Ojeda J., Esparza M.A.G.-R., Majluf-Cruz A., García-Chavez J., et al. | 2019 | INTERNATIONAL JOURNAL OF HEMATOLOGY | WoS-id: 000481420500006
Scopus-id: 2-s2.0-85067038595
| 8 | 8 |
| 15 | INSIGHT MM: A large, global, prospective, non-interventional, real-world study of patients with multiple myeloma | Coautor: Vela-Ojeda J., Costello C., Davies F.E., Cook G., et al. | 2019 | FUTURE ONCOL | WoS-id: 000488871600002
Scopus-id: 2-s2.0-85065701584
| 26 | 25 |
| 16 | Description of CD8+ regulatory T lymphocytes and their specific intervention in Graft-versus-Host and infectious diseases, autoimmunity, and cancer | 2ᵒ autor: Vela-Ojeda J., Vieyra-Lobato M.R., Montiel-Cervantes L., López-Santiago R., et al. | 2018 | JOURNAL OF IMMUNOLOGY RESEARCH | WoS-id: 000441940000001
Scopus-id: 2-s2.0-85055617828
| 53 | 59 |
| 17 | Prognostic Value of CD95, Active Caspase-3, and Bcl-2 Expression in Adult Patients with De Novo Acute Lymphoblastic Leukemia | Coautor: Vela-Ojeda J., Montiel-Cervantes L.A., Reyes-Maldonado E., Garcia-Chavez J., et al. | 2018 | Archives Of Medical Research | WoS-id: 000445443700006
Scopus-id: 2-s2.0-85045550608
| 2 | 3 |
| 18 | The Latin American experience of allografting patients with severe aplastic anaemia: Real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants | Coautor: Vela-Ojeda J., Gómez-Almaguer D., Vázquez-Mellado A., Navarro-Cabrera J.R., et al. | 2017 | BONE MARROW TRANSPL | WoS-id: 000393936300007
Scopus-id: 2-s2.0-84983541850
| 5 | 5 |
| 19 | Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia | Coautor: Vela-Ojeda J., Ponciano-Gómez A., Martínez-Tovar A., Olarte-Carrillo I., et al. | 2017 | TUMOR BIOLOGY | WoS-id: 000400268800025
Scopus-id: 2-s2.0-85031691388
| 29 | 17 |
| 20 | Maternal obesity associated with increase in natural killer T cells and CD8+ regulatory T cells in cord blood units | Coautor: Vela-Ojeda J., Gonzalez-Espinosa L.O., Montiel-Cervantes L.A., Guerra-Márquez A., et al. | 2016 | Transfusion | WoS-id: 000378555700013
Scopus-id: 2-s2.0-84958063912
| 16 | 15 |
| 21 | Risk Factors for Thrombosis Development in Mexican Patients | Coautor: Vela-Ojeda J., Zavala-Hernández C., Hernández-Zamora E., Martínez-Murillo C., et al. | 2015 | ANNALS OF VASCULAR SURGERY | WoS-id: 000363475300021
Scopus-id: 2-s2.0-84951847022
| 7 | 7 |
| 22 | Proteína CD200 de mal pronóstico en pacientes con mieloma múltiple | 1ᵉʳ autor: Vela-Ojeda J., García-Ruiz Esparza M.A., Padilla-González Y., Pérez-Retiguin F., et al. | 2015 | Revista Médica Del Instituto Mexicano Del Seguro Social | Scopus-id: 2-s2.0-84969441830
| 0 | 3 |
| 23 | Hematopoietic cell transplantation for primary plasma cell leukemia: Results from the Center for International Blood and Marrow Transplant Research | Coautor: Vela-Ojeda J., Mahindra A., Kalaycio M.E., Vesole D.H., et al. | 2012 | Leukemia | WoS-id: 000303883500029
Scopus-id: 2-s2.0-84860778432
| 74 | 88 |
| 24 | CD133+CD34+ and CD133+CD38+ blood progenitor cells as predictors of platelet engraftment in patients undergoing autologous peripheral blood stem cell transplantation | Coautor: Vela Ojeda J., Camacho Villa A.Y., Reyes Maldonado E., Montiel Cervantes L.A. | 2012 | TRANSFUS APHER SCI | WoS-id: 000304583900004
Scopus-id: 2-s2.0-84860442677
| 6 | 8 |
| 25 | Serum calcium is an independent prognostic factor of overall survival in Mexican patients with multiple myeloma | Coautor: Vela-Ojeda J., Maillet D., Montiel-Cervantes L., Padilla-González Y., et al. | 2012 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000304850200003
Scopus-id: 2-s2.0-84861681840
| 8 | 9 |
| 26 | Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia | Coautor: Ojeda J.V., Najera Chuc A.E., Cervantes L.A.M., Retiguin F.P., et al. | 2012 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | WoS-id: 000306547600020
Scopus-id: 2-s2.0-84864340451
| 39 | 40 |
| 27 | [Hematopoietic cells raising with plerixafor in non-Hodgkin lymphoma]. [Movilización de células hematopoyéticas con plerixafor en linfoma no Hodgkin folicular.] | Coautor: Vela-Ojeda J., Pérez-Lozano U., Tripp-Villanueva F., Ramírez-Alvarado A., et al. | 2012 | Revista Médica Del Instituto Mexicano Del Seguro Social | Scopus-id: 2-s2.0-84875676029
| 0 | 0 |
| 28 | Serum calcium is an independent prognostic factor of overall survival in Mexican patients with multiple myeloma (Revista de Investigacion Clinica (2012) 64, 1, (17-24)) | Coautor: Vela-Ojeda J., Maillet D., Montiel-Cervantes L., Padilla-González Y., et al. | 2012 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | Scopus-id: 2-s2.0-84874794006
| 0 | 0 |
| 29 | Allogeneic bone marrow transplantation for chronic myeloid leukemia. A single center experience | 1ᵉʳ autor: Vela-Ojeda J., Tripp-Villanueva F., Sánchez-Cortés E., Ayala-Sánchez M., et al. | 2000 | Archives Of Medical Research | WoS-id: 000088345300013
Scopus-id: 2-s2.0-0034603604
| 7 | 7 |
ID's SCOPUS 